Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12290 from 12311 pages
No results were found for the filter!
BM635 hydrochloride
BM635 hydrochloride

Item number: TGM-T62358-100mg

Description: BM635 hydrochloride is an MmpL3 inhibitor that exhibits significant anti-Divergent bacteriophage effects, inhibiting the binding of Divergent bacteriophage H37Rv (MIC50: 0.08 µM). Exposure to BM635 hydrochloride was doubled in vivo compared to free BM635. Target: Others
MW: 428.97 D
From 1,440.00€ *
Review
4,5'-Dimethylangelicin-NHS
4,5'-Dimethylangelicin-NHS

Item number: TGM-T62365-100mg

Description: 4,5'-Dimethylangelicin-NHS is an NHS-containing, modified 4,5'-Dimethylangelicin. 4,5'-Dimethylangelicin is a carbofuran coumarin that exhibits photochemical and photosensitivity properties. 4,5'-Dimethylangelicin has the potential to be a photochemical agent. Target: Others
MW: 429.44 D
From 1,440.00€ *
Review
TH-6
TH-6

Item number: TGM-T62366-100mg

Description: TH-6 is a potent inhibitor of HDAC, acting on HDAC1 (IC50: 0.115 µM), HDAC2 (IC50: 0.135 µM), HDAC3 (IC50: 0.242 µM), HDAC6 (IC50: 0.138 µM), HDAC8 (IC50: 2.120 µM). TH-6 inhibits cell migration and invasion and exhibits anti-tumour effects. Target: Others
MW: 429.44 D
From 1,137.00€ *
Review
Enpp-1-IN-7
Enpp-1-IN-7

Item number: TGM-T62368-100mg

Description: Enpp-1-IN-7 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1), which has broad specificity and cleaves a wide range of substrates, including phosphodiester bonds and pyrophosphate bonds of nucleotides and nucleotides. Enpp-1-IN-7 has potential applications in cancer...
MW: 429.45 D
From 1,440.00€ *
Review
XR8-69
XR8-69

Item number: TGM-T62928-100mg

Description: XR8-69, a SARS-CoV-2 PLpro inhibitor, exhibits a low micromolar antiviral effect in SARS-CoV-2 infected human cells. Target: Others
MW: 462.61 D
From 1,440.00€ *
Review
GT-055
GT-055

Item number: TGM-T62930-100mg

Description: GT-055 (LCB18-055) is a novel inhibitor of broad-spectrum beta-lactamase. Target: Others
MW: 463.39 D
From 1,440.00€ *
Review
Antiangiogenic agent 2
Antiangiogenic agent 2

Item number: TGM-T62931-100mg

Description: Antiangiogenic agent 2 (compound 3b) is a potent thymidine phosphorylase inhibitor (IC50: 39.71 µM) with demonstrated anti-angiogenic effects. Target: Others
MW: 463.5 D
From 1,440.00€ *
Review
NS2B/NS3-IN-2
NS2B/NS3-IN-2

Item number: TGM-T62932-100mg

Description: NS2B/NS3-IN-2 is a potent, covalent inhibitor of dengue virus (DENV) NS2B/NS3 with an IC50 of 6.0 nM and a Ki of 0.66 µM. It significantly increases cell viability and exhibits no cytotoxicity. Target: Others
MW: 463.51 D
From 1,440.00€ *
Review
ZLHQ-5f
ZLHQ-5f

Item number: TGM-T62934-100mg

Description: ZLHQ-5f is a dual inhibitor of CDK2 and Topo I, acting on CDK2/CycA2 (IC50: 0.145 µM). ZLHQ-5f has a good safety profile by blocking the cell cycle of HCT116 cells in S phase and inducing apoptosis. Target: Others
MW: 463.53 D
From 1,440.00€ *
Review
Anticancer agent 26
Anticancer agent 26

Item number: TGM-T62935-100mg

Description: Anticancer agent 26 is a promising candidate for cancer therapy and deserves further development. Target: Others
MW: 463.57 D
From 1,440.00€ *
Review
SHR2415
SHR2415

Item number: TGM-T62939-100mg

Description: SHR2415 is a selective, potent, orally active inhibitor of ERK1/2. SHR2415 inhibits ERK1 (IC50: 2.8 nM) and ERK2 (IC50: 5.9 nM). SHR2415 exhibits high potency in Colo205 cells (IC50: 44.6 nM). SHR2415 can be used in cancer research. Target: Others
MW: 463.92 D
From 1,440.00€ *
Review
ZLWT-37
ZLWT-37

Item number: TGM-T62943-100mg

Description: ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 µM) and CDK2 (IC50: 0.054 µM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis. Target: Others
MW: 464 D
From 1,440.00€ *
Review
12290 from 12311 pages